Anita Laloo
Rheumatology · Fort Lauderdale, FLNPI 1427316413
Payments from drug & device makers
Across 42 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$130
- Novo Nordisk$102
- Exact Sciences$58
- Johnson & Johnson$58
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$53
- Medtronic$50
- plus $395 from 16 others
What the payments were for
- Food & beverage$81296%
- Education$202%
- Entertainment$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 7 | $130 |
| Novo Nordisk | 5 | $102 |
| Exact Sciences | 3 | $58 |
| Johnson & Johnson(2 entities) | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Medtronic | 1 | $50 |
| Astellas Pharma US Inc | 2 | $49 |
| Lilly USA, LLC | 2 | $35 |
| AstraZeneca | 2 | $35 |
| AbbVie | 2 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Viiv Healthcare Company | 1 | $23 |
| Verity Pharmaceuticals Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Optos, Inc. | 1 | $14 |
How this compares
$846 in reported general payments places this provider in the 20th percentile of 453 rheumatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 16 | $176 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Fort Lauderdale
- Martha Hernandez IllasFort Lauderdale$25M
- Carlos SesinMiami Beach$19M
- Guillermo ValenzuelaPlantation$14.2M
- Marimer Rensoli VelazquezMiami$12.2M
- Robert LevinClearwater$11M
- Jigar ShahMargate$5.6M
- Michael BubbGainesville$3.3M
- Vipul JoshiBrandon$3.1M
- Alvin WellsDestin$2.9M
- Benidecto FernandezHialeah$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.